The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416.
LPL Financial Holdings Inc
LPLA · NASDAQ · USD · Market cap $22.2B · 9,901 employees
LPL Financial Holdings Inc., together with its subsidiaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at institutions in the U…
FAIL · Does not pass the screenPrice as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price300.89 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 3.63)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $335.97 to $559.95, base estimate $422.73 (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 3.63, read 2026-11-01
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
LPL Financial Holdings Inc holds its Distribution at $300.89. Elevated stress, defensive posture warranted, held for 2 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 2 days |
| Price at the screen | $300.89 |
| Valuation | 16.26 trailing · 9.50 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.54 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Capital Markets
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Capital Markets | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
LPL Financial does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LPLA's ethical verdict changes
Today LPLA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 26% discount to our $422.73 fair value, narrow competitive moat, 17.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 28.8% discount to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +32% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $422.73, with a range of $335.97 to $559.95, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLPL Financial fails our ethical screen outright
Independent advisors in every state route client money through platforms that bundle brokerage and advice. LPL Financial delivers exactly that service at scale, with revenue up 35 percent and a 20 percent return on equity. On paper the 11 times forward earnings and narrow moat look reasonable next to the 29 percent gap to our fair value.
We pass because the business sits in capital markets, an industry our screen excludes on principle. No valuation discount or analyst target at 401 dollars changes that line. The ethical filter exists to keep us out of entire sectors regardless of growth or cash generation.
Profit margins sit at just 5 percent, leaving little room for regulatory or market shocks common in this field. Currency and interest-rate swings add further pressure that the narrow moat does little to offset. Analysis, not advice.
| Forward P/E | 9.5xcheap for a company growing this fast |
| Trailing P/E | 16.3xreasonably valued |
| EPS, trailing | 17.45 |
| EPS, forward | 29.86 |
| Revenue growth | +17.8%steady growth |
| Profit margin | 7.0%thin but positive margins |
| Return on equity | 25.7%an exceptional return on shareholder capital |
| Dividend yield | 44.00% |
| Debt to equity | 1.34a meaningful debt load worth watching |
| Current ratio | 2.58comfortably covers its short-term bills |
| Beta | 0.54steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 260.15 - 400.16 |
| Moat | NARROW |
| Market cap | $22.2B |
| Employees | 9,901 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLPLA trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (14 analysts) rates it buy, with a mean price target of $416.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- LPL Financial (LPLA) Stock Gets Fair Value Trim As Analysts Weigh Growth And Integration Yahoo Finance · 7d ago
- LPL Financial Holdings (LPLA) Faces A Valuation Test After Earnings And Dividend Update Yahoo Finance · 7d ago
- Week’s Best: Former LPL Advisor Pleads Guilty to Wire Fraud Yahoo Finance · 7d ago
- 1 value stock with exciting potential and 2 we question Yahoo Finance · 7d ago
- What Just Happened To LPL Financial Stock? Yahoo Finance · 8d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-06-11 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-06-05 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2025-04-02 | Val Hoyle | Democrat | Sale | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $288.73 | +0.9% | $0.30 | $1,010 | +1.0% |
| 2 months | $312.20 | -6.7% | $0.30 | $934 | -6.6% |
| 3 months | $289.31 | +0.7% | $0.30 | $1,008 | +0.8% |
| 6 months | $386.67 | -24.7% | $0.60 | $755 | -24.5% |
| 1 year | $377.84 | -22.9% | $1.20 | $774 | -22.6% |
| 2 years | $278.66 | +4.5% | $2.40 | $1,054 | +5.4% |
| 3 years | $201.92 | +44.2% | $3.60 | $1,460 | +46.0% |
| 5 years | $135.76 | +114.5% | $5.70 | $2,187 | +118.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LPLA does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.